Title: “The Mpox outbreak in Montreal: A model for responding to emerging epidemics”
Speaker: Dr. Sapha Barkati and Dr. Marina Klein
Educational Objectives:
Understand the epidemiology, clinical presentation, management and prevention of mpox.
Recognize the importance of community engagement in responding to public health threats.
Identify the key ingredients needed to implement a rapid response to an emerging epidemic.
Appreciate the value of local, national and international collaboration, knowledge exchange and research to catalyze epidemic control.
Biosketch:
Dr. Sapha Barkati is an Assistant Professor of infectious diseases and medical microbiology. She completed a master’s degree in virology and was trained in infectious diseases and medical microbiology at Université de Montréal. She was subsequently trained in tropical medicine and parasitology at McGill University. Dr Barkati is the educational director of the J.D MacLean Centre for Tropical diseases at McGill University and the director of this site within the international GeoSentinel network. Since 2018, she has become an established international faculty of the Gorgas Diploma Course, Instituto De Medicina Tropical “Alexander Von Humboldt” at a Universidad Peruana Cayetano Heredia in Lima, Peru. She is the chair of the International Society of Travel Medicine (ISTM) Migration and Refugee Interest Group Council. Dr Barkati is also an active member of the Comité d’immunisation du Québec (CIQ). Her main interest is the epidemiology of tropical and parasitic diseases in vulnerable individuals, migrants and immunocompromised hosts.
Dr. Marina Klein is a Professor of Medicine at McGill University, in the Division of Infectious Diseases/Chronic Viral Illnesses Service where she is Research Director and leads the MI4 Clinical Research Platform. Trained in Medicine, Infectious Disease, microbial pathogenesis, Epidemiology and Biostatistics, she is an internationally recognized expert in HIV and Hepatitis C (HCV) observational research and clinical trials. She is National co-director of the Canadian Institutes of Health Research (CIHR) – Canadian HIV Trials Network (CTN) and holds a Tier 1 Canada Research Chair in Clinical and Epidemiologic Studies of Chronic Viral Infections in Vulnerable Populations. She served on the International AIDS Society Governing Council and its executive committee as representative for North America between 2012-2020. She is an Executive committee member and founding investigator in the NIH funded North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Dr Klein is leading “Métropoles sans Hep C”, an innovative community-focused program aiming to make Montreal the first city in North America to eliminate HCV.
source